Deferoxamine In the Treatment of Aneurysmal Subarachnoid Hemorrhage (aSAH)
A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 120 participants.
Also called NCT04566991
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 120 participants
- Sponsor
- Aditya S. Pandey, MD
- Registry
-
NCT04566991
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT04566991. Randomized; double masking; primary purpose treatment. Start 2022-03-20 (actual); primary completion 2029-10 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Deferoxamine In the Treatment of Aneurysmal Subarachnoid Hemorrhage (aSAH)
- Acronym
- DISH
- Condition
- Aneurysmal Subarachnoid Hemorrhage
- Intervention (Drug)
- Deferoxamine
- Intervention (Drug)
- Placebo
- Lead sponsor
- Aditya S. Pandey, MD
Record details
- Record id
cardio:ct-nct04566991- Content hash
846fcbaf43731613b88b450a6e7a449df3d133e02e0048a5fc6ddf5e2b1848ad